Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 1:15:1297798.
doi: 10.3389/fpsyt.2024.1297798. eCollection 2024.

Personalized medicine in old age psychiatry and Alzheimer's disease

Nikias Siafarikas  1
Affiliations
Review

Personalized medicine in old age psychiatry and Alzheimer's disease

Nikias Siafarikas. Front Psychiatry. .

Abstract

Elderly patients show us unfolded lives with unique individual characteristics. An increasing life span is associated with increasing physical and mental disease burden. Alzheimer's disease (AD) is an increasing challenge in old age. AD cannot be cured but it can be treated. The complexity of old age and AD offer targets for personalized medicine (PM). Targets for stratification of patients, detection of patients at risk for AD or for future targeted therapy are plentiful and can be found in several omic-levels.

Keywords: Alzheimer’s disease; dementia; old age psychiatry; personalized medicine; precision medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The clinical phenotype needs to be widened with omics data to identify latent subgroups and PM targets.
Figure 2
Figure 2
Systematic literature search.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Abrahams E, Ginsburg GS, Silver M. The Personalized Medicine Coalition: goals and strategies. Am J Pharmacogenomics. (2005) 5:345–55. doi: 10.2165/00129785-200505060-00002 - DOI - PubMed
    1. Wium-Andersen IK, Vinberg M, Kessing LV, McIntyre RS. Personalized medicine in psychiatry. Nord J Psychiatry. (2017) 71:12–9. doi: 10.1080/08039488.2016.1216163 - DOI - PubMed
    1. Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Steril. (2018) 109:952–63. doi: 10.1016/j.fertnstert.2018.05.006 - DOI - PMC - PubMed
    1. König IR, Fuchs O, Hansen G, von Mutius E, Kopp MV. What is precision medicine? Eur Respir J. (2017) 50. doi: 10.1183/13993003.00391-2017 - DOI - PubMed
    1. Hampel H, Nisticò R, Seyfried NT, Levey AI, Modeste E, Lemercier P, et al. . Omics sciences for systems biology in Alzheimer’s disease: state-of-the-art of the evidence. Ageing Res Rev. (2021) 69:101346. doi: 10.1016/j.arr.2021.101346 - DOI - PubMed

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

LinkOut - more resources

-